Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522148 | SCV000621333 | pathogenic | not provided | 2023-09-08 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36130591, 33874999) |
The Genetics Institute, |
RCV000627090 | SCV000747834 | likely pathogenic | Au-Kline syndrome | 2018-04-01 | criteria provided, single submitter | clinical testing | This sequence change replaces Glutamic acid with Lysine at codon 85 of the HNRNPK protein p.(Glu85Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is not present in population databases (gmomAD, dbSNP,). This variant was found in an individual with clinical symptomes compatible with Au-Kline syndrome (MIM:616580 ), de novo inheritance was confirmed. ClinVar contains an entry for this variant (Variation ID: 452520). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C55"). |
Ambry Genetics | RCV001267488 | SCV001445669 | uncertain significance | Inborn genetic diseases | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000522148 | SCV001447542 | likely pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
3billion | RCV000627090 | SCV002572966 | uncertain significance | Au-Kline syndrome | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.29; 3Cnet: 0.98). Same nucleotide change resulting in same amino acid change has been previously reported as likely pathogenic and uncertain significance for HNRNPK -related disorder (ClinVar ID: VCV000452520). Threrefore, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |
MGZ Medical Genetics Center | RCV000627090 | SCV002578985 | likely pathogenic | Au-Kline syndrome | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000522148 | SCV004042360 | likely pathogenic | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | HNRNPK: PS2, PM2, PS4:Moderate, PP2 |
OMIM | RCV000627090 | SCV002605170 | pathogenic | Au-Kline syndrome | 2022-11-18 | no assertion criteria provided | literature only |